# Artemis Medicare Services Ltd (ARTEMISMED)
> Exchange: NSE | Sector:  | ISIN: 

## Price
Current Price: ₹273.03
Day Change: -2.25%
52W High: ₹297.5
52W Low: ₹203.35
Market Cap: ₹0 Cr

## Valuation
P/E: 120.18
P/B: 4.65
EPS: ₹2.29
Book Value: ₹59.16
Dividend Yield: 0%

## Returns
1Y Return: 11.99%

## Profitability
ROE: 11.63%
ROCE: 16.22%
Debt/Equity: 0.28
Revenue Growth: 14.1%
Profit Growth: 28.7%
EBITDA Margin: 19.62%
Operating Margin: 13.85%

## About
Artemis Medicare Services Ltd is a listed Indian business company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Unknown
Industry: Unknown
Sub Industry: Unknown

## Business Model
Overview: Artemis Medicare Services Ltd makes money through Core products and services, Customer and channel-led sales, Ancillary operating income in its operating segment. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within its sector.
Source: Derived from stock data
Revenue Streams:
- Core products and services
- Customer and channel-led sales
- Ancillary operating income
Operating Model:
- Converts operating assets, distribution reach, and customer demand into revenue across its chosen markets.
- Scale, margins, working capital, capital allocation, and competitive intensity drive shareholder returns.
Recent Context:
- Concall Transcript: Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication

## Access
Current tier: anonymous
More history: Register free to see 4 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:00.755Z
Price History Updated: 2026-05-17T21:24:15.387Z
Latest Price History Date: 2026-05-17
Technicals Updated: 2026-05-17T21:24:15.387Z
Quant Updated: 2026-05-17T21:24:15.387Z
Sentiment Updated: 2026-05-17T21:24:15.387Z
Financials Status: stale
Financials Updated: 2026-05-19T16:57:27.534Z
Financials Last Attempt: 2026-05-19T16:57:27.534Z
Financials Provider Tried: yahoo
Latest P&L Period: Mar 2020
Latest Balance Sheet Period: Mar 2020
Latest Cash Flow Period: Mar 2020

## P&L (Mar 2020)
Revenue: ₹547 Cr
Operating Profit: ₹66 Cr (OPM 12%)
Net Profit: ₹20 Cr
Tax: ₹37 Cr

## Annual P&L History
Mar 2020: Rev ₹547Cr | PAT ₹20Cr | OPM 12%
Mar 2021: Rev ₹565Cr | PAT ₹19Cr | OPM 11%
Mar 2022: Rev ₹408Cr | PAT ₹6Cr | OPM 9%

## Balance Sheet (Mar 2020)
Total Assets: ₹554 Cr
Total Liabilities: ₹554 Cr
Borrowings: ₹114 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Devlina  Chakravarty DMRD, DNB, M.D., Radiology, CEO, MD & Executive Director
- Sanjiv Kumar Kothari, Chief Financial Officer
- Poonam  Makkar, Company Secretary & Compliance Officer
- Pradeep Kumar Saha, Group Chief Information Officer
- Rudra Narayan Acharjee, Head of Investor Relations, M&A and Organization Growth Strategy

---
Source: rupiya.io/stocks/artemismed
Disclaimer: For research and education only. Not investment advice.